{"id":407223,"date":"2025-09-18T16:10:04","date_gmt":"2025-09-18T14:10:04","guid":{"rendered":"https:\/\/medizinonline.com\/?p=407223"},"modified":"2025-09-04T16:14:42","modified_gmt":"2025-09-04T14:14:42","slug":"le-rechallenge-des-anti-egfr-comme-option-therapeutique-valable-en-troisieme-ligne","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/le-rechallenge-des-anti-egfr-comme-option-therapeutique-valable-en-troisieme-ligne\/","title":{"rendered":"Le \u00abrechallenge\u00bb des anti-EGFR comme option th\u00e9rapeutique valable en troisi\u00e8me\u00a0ligne"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong><strong>Le congr\u00e8s annuel de l\u2019ASCO qui s\u2019est tenu cette ann\u00e9e du 30&nbsp;mai au 3&nbsp;juin&nbsp;2025 \u00e0 Chicago, aux \u00c9tats-Unis, a \u00e9t\u00e9 l\u2019occasion d\u2019une pr\u00e9sentation des donn\u00e9es actuelles de l\u2019\u00e9tude&nbsp;FIRE-4 sur la r\u00e9administration (<em>rechallenge<\/em>) du traitement anti-EGFR dans le cancer colorectal m\u00e9tastatique (mCRC) pr\u00e9sentant le g\u00e8ne&nbsp;<em>RAS<\/em> de type&nbsp;sauvage (wt). Les donn\u00e9es montrent que la r\u00e9administration est une option th\u00e9rapeutique valable en troisi\u00e8me&nbsp;ligne dans le mCRC avec g\u00e8ne&nbsp;<em>RAS<\/em>&nbsp;wt et que la biopsie liquide aide \u00e0 s\u00e9lectionner les patientes et patients susceptibles de b\u00e9n\u00e9ficier d\u2019une telle r\u00e9administration du traitement [1].<\/strong><\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fle-rechallenge-des-anti-egfr-comme-option-therapeutique-valable-en-troisieme-ligne%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Le congr\u00e8s annuel de l\u2019ASCO qui s\u2019est tenu cette ann\u00e9e du 30&nbsp;mai au 3&nbsp;juin&nbsp;2025 \u00e0 Chicago, aux \u00c9tats-Unis, a \u00e9t\u00e9 l\u2019occasion d\u2019une pr\u00e9sentation des donn\u00e9es actuelles de l\u2019\u00e9tude&nbsp;FIRE-4 sur la&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fle-rechallenge-des-anti-egfr-comme-option-therapeutique-valable-en-troisieme-ligne%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":17461,"featured_media":407219,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":" contenu sponsoris\u00e9","footnotes":""},"category":[11345,11527,11414,11467,11389,11535,11549],"tags":[],"powerkit_post_featured":[],"class_list":["post-407223","post","type-post","status-publish","format-standard","has-post-thumbnail","category-contenu-des-partenaires","category-etudes","category-gastro-enterologie-et-hepatologie","category-medecine-pharmaceutique","category-oncologie","category-rapports-de-congres","category-rx-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-04 19:35:12","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/407223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/17461"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=407223"}],"version-history":[{"count":3,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/407223\/revisions"}],"predecessor-version":[{"id":408852,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/407223\/revisions\/408852"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/407219"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=407223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=407223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=407223"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=407223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}